CDC42 and colon adenocarcinoma: Specifically, decreased expression of the TAGLN gene was associated with survival extension (P-value = 0.014) (Fig. 7B), while increased expression of the CDC42 gene was associated with improved survival in COAD patients (P-value = 0.035) (Fig. 7A).